Metrics as of 10/15/2026, 07:27 AM (Berlin time), refresh in progress.
Sotera Health Company
Sotera Health Company, headquartered in Broadview Heights, operates within the Healthcare sector. The company delivers essential sterilization, laboratory testing, and advisory services to a global clientele spanning North America, Europe, and various international regions. Its sterilization capabilities encompass…
Company description based on the data provider's company data, AI-assisted, created on 16/10/2026. Not investment advice.
1D
-1.0%
1W
-0.9%
1M
-7.4%
6M
+9.8%
YTD
+1.4%
1Y
+9.6%
2Y
+12.4%
5Y
-31.6%
10Y
–
Next earnings date
03/11/2026 (in 17 days)
Volatility around earnings
~9% stronger price swings than usual
Visible after free registration
Visible after free registration
Visible after free registration
Visible after free registration
Visible after free registration
Visible after free registration
Visible after free registration
Visible after free registration
Visible after free registration
Visible after free registration
Register for free
Unlock all 11 scores
Deterministically calculated from financial metrics, not investment advice. Updated nightly, last on 17/10/2026.
Robust business model that benefits noticeably from at least one megatrend.
2 more assignments (Enabler/Second row) Pro-only.
Sotera Health Company provides specialized services in the fields of sterilization, laboratory testing, and consulting. The portfolio encompasses procedures such as gamma irradiation, electron beam, and ethylene oxide processing, as well as microbiological analyses through the Nelson Labs division. Revenue is generated primarily through services, with a smaller contribution from physical products. The addressed industries include, among others, medical devices, pharmaceuticals, as well as the food and agricultural sectors.
PRICE TARGET LOW
US$19.00
CONSENSUS
US$21.33
MEDIAN
US$20.00
PRICE TARGET HIGH
US$25.00
0
STRONG BUY
11
BUY
0
HOLD
1
SELL
0
STRONG SELL
12
TOTAL · Buy
As of: 14/10/2026
P/E
31.21
P/B
7.68
EV/EBITDA
13.17
RETURN ON EQUITY
8.1%
NET MARGIN
16.7%
DEBT/EQUITY
3.41
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
FREE FLOAT
54.1%
FLOAT SHARES
154,135,655
AVG. DAILY VOLUME (30D)
1,969,438
Petras Michael B. Jr.
Petras Michael B. Jr.
Rutz Michael P
Lyons Jonathan M.
Neary James
Sotera Health Company is a company in the Healthcare sector, Medical - Diagnostics & Research industry, headquartered in United States.
The CEO is Alton E. Shader, the company employs around 3,000 people.
The IPO was on 20/11/2020; the stock trades on NASDAQ under the ticker SHC.
12 analysts rate the stock, the consensus is Buy (as of 14/10/2026).
The average price target is US$21.33, ranging from US$19.00 to US$25.00, with a median of US$20.00.
This is an external assessment, not a statement by Market Jury.
The next earnings date is 03/11/2026.
Around past earnings, price swings were roughly 9% stronger than usual.
No, Sotera Health Company currently does not pay a dividend.
Comparable stocks include Thermo Fisher Scientific, Danaher, Natera, Agilent Technologies, IQVIA Holdings, Waters, Illumina and IDEXX Laboratories.
Clicking "Analyze stock" lets five strategies assess Sotera Health Company against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.